Brand profile · Biotechnology Research

DotBio

Singapore-based DotBio operates in Biotechnology Research. Ownership is privately held; it publishes at dotbiopharma.com. It holds one address on record, all in Singapore. The record counts 23 people. Tagged oncology and DotBody technology. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Seed, US$5.6M. It is listed alongside six similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2018 1 entity UEN 1 office country US$ 5.6M Seed
Registry verified · ACRA

Key facts

Counted staff
23
self-reported 2–10 band
Founded
2018
8 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
4
Seed · Sep 2023 · US$ 5.6M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

DotBio: 1 registry entityDotBio is linked to 1 registry entity: DOTBIO PTE. LTD. (UEN 201715654D, confirmed).DotBioDOTBIO PTE. LTD.UEN 201715654DConfirmed · ACRA
Show as table · DotBio: 1 registry entity
DotBio: 1 registry entity
DOTBIO PTE. LTD.UEN 201715654D
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit www.dotbiopharma.com

Specialties

All 1 specialty
  • Oncology and DotBody technology

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countrySG

All codes: SG

Addresses

  • SG1 Research Link; Singapore, 11Primary

Grid intelligence Members

Funding

Last round · 7 September 2023US$ 5.6MSeed · investors: Prox Ventures, Gaorong Capital
Rounds4
Round typeSeed · venture round
Amount (USD)5,600,000
Stage rank2
Investors named2
Since last round2 yr 4 mo

Funding

4 funding roundsFunding timeline. Latest round 7 Sep 2023: Seed, US$ 5.6M.20182026SeedUS$ 5.6M4 rounds
Show as table · 4 funding rounds
4 funding rounds
Rounds4
Axis2018 to 2026
Seed · 7 Sep 2023US$ 5.6M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under DotBio?

One Singapore entity on ACRA. DOTBIO PTE. LTD. (UEN 201715654D), high confidence.

How many people work at DotBio?

The record holds 23 counted staff profiles at January 2026, above the self-reported 2–10 band.

Where does DotBio have offices?

One address on record, Singapore only. Primary: 1 Research Link, Singapore, 11.

Has DotBio raised funding?

Four rounds. Latest 7 September 2023: Seed, US$5,600,000, investors Prox Ventures and Gaorong Capital.

What does DotBio list as its specialties?

One tag on the brand's own list, among them Oncology and DotBody technology.

Which companies are listed alongside DotBio?

11 profiles list DotBio as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. Acoerela and Avecris list it back.

What is DotBio's website?